Every SEC Form 3/4/5 on record for this filer (CIK 2112339) — 1 issuer, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Interim Chief Legal Officer | 2026-02-23 → 2026-03-09 | 4 | −$163,749 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TEVA | 2026-03-05 | Sell | 1,127 | $31.67 | $35,692 | 10,914 |
| TEVA | 2026-03-04 | Sell | 1,489 | $32.46 | $48,333 | 6,181 |
| TEVA | 2026-03-04 | Sell | 1,186 | $32.46 | $38,498 | 8,461 |
| TEVA | 2026-03-03 | Sell | 1,274 | $32.36 | $41,227 | 2,926 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.